MDM2 Copy Numbers in Well-Differentiated and Dedifferentiated Liposarcoma

被引:53
作者
Ware, Patrick L. [1 ]
Snow, Anthony N. [3 ]
Gvalani, Maya [2 ]
Pettenati, Mark J. [2 ]
Qasem, Shadi A. [1 ]
机构
[1] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA
[2] Wake Forest Sch Med, Dept Mol Cytogenet, Winston Salem, NC USA
[3] Brown Univ, Warren Alpert Med Sch, Dept Pathol, Providence, RI 02912 USA
关键词
MDM2; FISH; Well-differentiated liposarcoma; Dedifferentiated liposarcoma; IN-SITU HYBRIDIZATION; SOFT-TISSUE TUMORS; CDK4; AMPLIFICATION; DIAGNOSIS; NEOPLASMS;
D O I
10.1309/AJCPLYU89XHSNHQO
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: MDM2 gene amplification is associated with well-differentiated (WDL) and dedifferentiated liposarcomas (DDL). Using fluorescent in situ hybridization (FISH), we sought to characterize various patterns of MDM2 amplification among the morphologic spectrum of liposarcoma. Methods: Forty-six cases of liposarcoma in various sites were examined and included 22 WDLs, 14 DLLs, and 10 negative control subjects. Results: The MDM2 amplification ratio (MDM2/CEP12) was lower in WDL (10.2) compared with DDL (18.3) cases (P = .0000002). An amplification ratio of 16 showed optimal sensitivity (0.86) and specificity (0.96) as a cutoff point for progression to DDL. Borderline areas, defined as tumors with increased cellularity and atypia but with preserved lipomatous differentiation, showed a significantly higher MDM2 ratio (17.5; P = .0007) compared with WDL. Central (retroperitoneal and intra-abdominal) tumors also showed a significantly higher MDM2 ratio than peripheral ones (P = .02). Conclusions: Differences in MDM2 amplification profiles among liposarcomas could help further define and predict progression to high-grade neoplasia.
引用
收藏
页码:334 / 341
页数:8
相关论文
共 15 条
[1]   Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours [J].
Aleixo, P. B. ;
Hartmann, A. A. ;
Menezes, I. C. ;
Meurer, R. T. ;
Oliveira, A. M. .
JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (12) :1127-1135
[2]   MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes -: A comparative analysis of 559 soft tissue neoplasms with genetic data [J].
Binh, MBN ;
Sastre-Garau, X ;
Guillou, L ;
de Pinieux, G ;
Terrier, P ;
Lagacé, R ;
Aurias, A ;
Hostein, I ;
Coindre, JM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (10) :1340-1347
[3]   Well-differentiated and dedifferentiated liposarcomas [J].
Coindre, Jean-Michel ;
Pedeutour, Florence ;
Aurias, Alain .
VIRCHOWS ARCHIV, 2010, 456 (02) :167-179
[4]  
Dei Tos A P, 2000, Ann Diagn Pathol, V4, P252, DOI 10.1053/adpa.2000.8133
[5]   Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma [J].
Dickson, Mark A. ;
Tap, William D. ;
Keohan, Mary Louise ;
D'Angelo, Sandra P. ;
Gounder, Mrinal M. ;
Antonescu, Cristina R. ;
Landa, Jonathan ;
Qin, Li-Xuan ;
Rathbone, Dustin D. ;
Condy, Mercedes M. ;
Ustoyev, Yelena ;
Crago, Aimee M. ;
Singer, Samuel ;
Schwartz, Gary K. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (16) :2024-+
[6]   Dedifferentiated liposarcoma - A clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation [J].
Henricks, WH ;
Chu, YC ;
Goldblum, JR ;
Weiss, SW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (03) :271-281
[7]   Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma [J].
Horvai, Andrew E. ;
DeVries, Sandy ;
Roy, Ritu ;
O'Donnell, Richard J. ;
Waldman, Frederic .
MODERN PATHOLOGY, 2009, 22 (11) :1477-1488
[8]   Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor [J].
Kashima, Takeshi ;
Halai, Dina ;
Ye, Hongtao ;
Hing, Sandra Nalini ;
Delaney, David ;
Pollock, Robin ;
O'Donnell, Paul ;
Tirabosco, Roberto ;
Flanagan, Adrienne Margaret .
MODERN PATHOLOGY, 2012, 25 (10) :1384-1396
[9]   The CDKN2A/CDKN2B/CDK4/CCND I Pathway is Pivotal in Well-Differentiated and Dedifferentiated Liposarcoma Oncogenesis. An Analysis of 104 Tumors [J].
Louis-Brennetot, Caroline ;
Coindre, Jean-Michel ;
Ferreira, Celine ;
Perot, Gaelle ;
Terrier, Philippe ;
Aurias, Alain .
GENES CHROMOSOMES & CANCER, 2011, 50 (11) :896-907
[10]   Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors [J].
Miura, Yasuhiro ;
Keira, Yoshiko ;
Ogino, Jiro ;
Nakanishi, Katsuya ;
Noguchi, Hiroko ;
Inoue, Tomomi ;
Hasegawa, Tadashi .
PATHOLOGY INTERNATIONAL, 2012, 62 (01) :16-27